Lucence to commercialize laser microfluidics for cancer biopsy - IDEX Health & ScienceIDEX Health & Science

    Disclaimer:

    The views, information, or opinions expressed in the Industry News RSS feed belong solely to the author and do not necessarily represent those of IDEX Health & Science and its employees.

    Lucence to commercialize laser microfluidics for cancer biopsy

    Article obtained from Optics.org RSS Feed.

    Palo Alto startup is working with Waseda University group on a new way to identify circulating tumor cells at an early stage.

    READ MORE
    Mar, 30 2021 |

    IDEX Health & Science is the global authority in fluidics and optics, bringing to life advanced optofluidic technologies with our products, people, and engineering expertise. Intelligent solutions for life.